Medial cortex is critically involved in self-referential processing. Little is known about how selective serotonin reuptake inhibitors (SSRIs) affect medial cortical activity during self-assessment. We hypothesized that a 3-week oral course of escitalopram,10 mg/day, would alter activity related to self-referential processing in medial cortex. Fifteen healthy females performed a self-assessment task during functional magnetic resonance imaging on two occasions -once after 3 weeks of placebo and once at the end of 3 weeks of escitalopram. Task conditions involved responding "yes" or "no" to whether various positive and negative adjectives described the subject (i.e., "self" evaluation trials) or the subject's best friend (i.e., "other" evaluation trials), whereas the comparison condition involved responding whether the valence of various adjectives was positive or negative (i.e., "word" evaluation trials). Behaviorally after escitalopram, subjects less frequently endorsed that negative adjectives described themselves. Three main neuroimaging results were observed: (1) increased activation in medial prefrontal cortex and posterior cingulate related to self minus word evaluation trials, (2) increased activation in posterior cingulate related to escitalopram minus placebo for self and word evaluation trials, and (3) drug by task interactions in the insula, cerebellum and prefrontal cortex. These results show that SSRIs change medial cortical activity and may alter self-evaluation.
Introduction
Reflection on one's internal feeling state is important for adaptive emotional experiences. A network of medial cortical structures is activated during self-referential processing (Fossati et al., 2003; Northoff et al., 2006) . Self-referential processing of emotional words activates medial prefrontal cortex (mPFC), posterior cingulate cortex (PCC) and precuneus (Yoshimura et al., 2009 ) -regions that are critically involved in self-generated emotional feelings and autobiographical memory (D'Argembeau et al., 2008; Gusnard et al., 2001; Northoff et al., 2006) . Medial cortical structures are also activated when individuals are "at rest" during neuroimaging experiments (Raichle et al., 2001) . Some have speculated that this activation occurs because subjects are in fact not "at rest", but rather are highly focused on autobiographical thoughts and memories (Mazoyer et al., 2001; Gusnard et al., 2001) .
Hyperactivity of medial cortical circuitry has been observed in psychiatric disorders such as major depressive disorder (MDD) (Kennedy et al., 2001; Mayberg et al., 1999) . Recent evidence shows that MDD individuals show hyperactivity in the mPFC during self-referential processing of negative words (Yoshimura et al., 2010) . Altered medial cortical activity in MDD may reflect an impaired ability to disengage from negative self-referential emotion processing in this disorder (Ellenbogen et al., 2002; Lyubomirsky et al., 1998; Matthews et al., 2009; Siegle et al., 2002; Wenzlaff, 1998) and could be related to dysregulated serotonin function. The anterior medial cortex (i.e., mPFC and anterior cingulate cortex (ACC)) may be differentially activated when individuals engage specifically in self-referential processing related to their hopes and aspirations, whereas the posterior medial cortex (i.e., PCC and precuneus) may be differentially activated when individuals engage specifically in self-referential processing related to their duties and obligations (Grimm et al., 2009; Johnson et al., 2009) . MDD individuals also show dysregulated activity of the cortical regions including dorsolateral prefrontal cortex (DLPFC), insula, ventral striatum and thalamus during self-referential processing (Grimm et al., 2009; Lemogne et al., 2009) .
The effects of serotonergic drugs on resting brain activity in medial cortex have been previously investigated using PET. Acute administration of the SSRI citalopram (40 mg of IV citalopram administered over 60 min on two consecutive days) was associated with decreased metabolism in the precuneus and PCC in healthy volunteers during resting PET (Smith et al., 2009) . A related study showed that chronic (i.e., 12 week) administration of the selective serotonin reuptake inhibitor
